Cleared Special

K193391 - BeneVision Central Monitoring System

K193391 is an FDA 510(k) clearance for BeneVision Central Monitoring System, manufactured by Shenzhen Mindray Bio-Medical Electronics Co., Ltd.. The device is a Class 2 Cardiovascular device with product code MSX cleared through the Special 510(k) pathway after a 167-day FDA review.

K193391 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
May 2020
Decision
167d
Days
Class 2
Risk

K193391 is an FDA 510(k) clearance for the BeneVision Central Monitoring System. Classified as System, Network And Communication, Physiological Monitors (product code MSX), Class II - Special Controls.

Submitted by Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on May 21, 2020 after a review of 167 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K193391

510(k) Number K193391 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 06, 2019
Decision Date May 21, 2020
Days to Decision 167 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
42d slower than avg
Panel avg: 125d · This submission: 167d
Pathway characteristics
Modification to existing cleared device.

MSX Device Classification - Class 2, Special Controls

Product Code MSX System, Network And Communication, Physiological Monitors
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MSX System, Network And Communication, Physiological Monitors

All 119
Devices cleared under the same product code (MSX) and FDA review panel - the closest regulatory comparables to K193391.
Smart Alarm Interface
K193421 · Boxview, LLC · Oct 2020
Aulisa Multiple Patient Digital Vital Sign Monitoring System
K202497 · Taiwan Aulisa Medical Devices Technologies, Inc. · Oct 2020
Spire Health Remote Patient Monitoring System
K192952 · Spire, Inc. D/B/A Spire Health · Jun 2020
Critical Alert CommonPath Enterprise
K193043 · Critical Alert · May 2020
Wearable Device, Wearable Package
K191272 · Current Health , Ltd. · Jul 2019
Philips IntelliVue XDS Software
K182637 · Philips Medizin Systeme Boeblingen GmbH · Apr 2019
K193391 · BeneVision Central Monitoring System
Download PDF FDA Summary Shenzhen Mindray Bio-…